News Releases & Statements

News Releases & Statements

FDA Approved Misc

FDA Approves New Targeted Treatment Option for Certain Forms of Acute Myeloid Leukemia in Adults

Posted On: December 2, 2022 Read More
Researcher

The Leukemia & Lymphoma Society’s Presence at ASH Showcases Progress to Advance Cures and Care for Blood Cancer Patients

Posted On: November 28, 2022

RYE BROOK, N.Y., November 28, 2022 – At the 64th Annual American Society of Hematology (ASH) Annual Meeting (December 10-13), The Leukemia & Lymphoma Society (LLS) will be presenting new research, leading sessions on the latest innovations in blood cancer treatment and equitable access to care, and proudly supporting hundreds of LLS-funded researchers who will share their findings. Read More

The

The Leukemia & Lymphoma Society Earns a Four-Star Rating From Charity Navigator

Posted On: November 16, 2022

Rye Brook, N.Y. - The Leukemia & Lymphoma Society is proud to announce that its strong financial health and ongoing accountability and transparency have earned LLS a Four-Star Rating from Charity Navigator. Read More

FDA-Approval-Misc

LLS Applauds FDA Approval of New Treatment Option for Pediatric Patients with Hodgkin Lymphoma

Posted On: November 11, 2022 Read More
FDA Approval Misc

Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood Diseases

Posted On: November 4, 2022 Read More
Shred for Red

Shred For Red: An Unstoppable Community Hits the Slopes to End Blood Cancer

Posted On: October 31, 2022 Read More
Breaking News Myeloma

FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma

Posted On: October 27, 2022 Read More
Fast Company

The Leukemia & Lymphoma Society Named in Fast Company’s Second Annual List of “Brands That Matter”

Posted On: October 24, 2022

[Rye Brook, NY], October 25, 2022 – Fast Company announced today its second annual Brands That Matter list, honoring brands that communicate and demonstrate brand purpose. These companies and nonprofits have achieved relevance through cultural impact and social engagement and authentically communicated their missions and ideals.

Read More

Media Requests

Please send all media-related inquiries and interview requests to mediarelations@lls.org.  An LLS representative will respond as soon as possible.